BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19183074)

  • 1. Mechanisms and significance of progenitor cell reduction in the metabolic syndrome.
    Fadini GP; Agostini C; Boscaro E; Avogaro A
    Metab Syndr Relat Disord; 2009 Feb; 7(1):5-10. PubMed ID: 19183074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk.
    Fadini GP; de Kreutzenberg SV; Coracina A; Baesso I; Agostini C; Tiengo A; Avogaro A
    Eur Heart J; 2006 Sep; 27(18):2247-55. PubMed ID: 16912055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial progenitor cell status in metabolic syndrome.
    Jialal I
    Metab Syndr Relat Disord; 2010 Jun; 8(3):193-5. PubMed ID: 20367241
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the "typical" cardiometabolic patient for risk of cardiovascular disease.
    Strobl DJ
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S21-2. PubMed ID: 19451255
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of the metabolic syndrome in obesity.
    Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Obes Rev; 2005 Nov; 6(4):283-96. PubMed ID: 16246214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms for vascular injury in the metabolic syndrome.
    Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T
    Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter's syndrome.
    Di Mambro A; Ferlin A; De Toni L; Selice R; Caretta N; Foresta C
    Mol Hum Reprod; 2010 Jun; 16(6):411-7. PubMed ID: 20228052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel component of the metabolic syndrome: the oxidative stress.
    Hopps E; Noto D; Caimi G; Averna MR
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):72-7. PubMed ID: 19747805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
    Müller A; Mulhall JP
    Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular repair by endothelial progenitor cells.
    Zampetaki A; Kirton JP; Xu Q
    Cardiovasc Res; 2008 Jun; 78(3):413-21. PubMed ID: 18349136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
    Després JP
    Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
    [No Abstract]   [Full Text] [Related]  

  • 18. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factor management: a practice guide.
    Perk J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.